Compugen (CGEN) Short-term Investments (2009 - 2026)
Compugen recorded quarterly Short-term Investments of $79.3 million in Q1 2026, up 73.33% quarter-over-quarter from $45.8 million in Q4 2025.
Compugen's Short-term Investments history runs 10 years deep, the most recent figure standing at $79.3 million for Q1 2026.
- In Q1 2026, Short-term Investments changed N/A year-over-year to $79.3 million; the TTM figure through Mar 2026 stood at $79.3 million (changed N/A YoY), while the FY2025 annual figure was $45.8 million, down 25.47% from the prior year.
- Short-term Investments came in at $79.3 million for Q1 2026 at Compugen, up from $45.8 million in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $79.3 million in Q1 2026 to a low of $11.7 million in Q4 2023.
- A 4-year average of $49.6 million and a median of $53.6 million in 2024 frame the typical range for Short-term Investments.
- Across the five-year window, Short-term Investments jumped 422.88% in 2024 and fell 25.47% in 2025, its largest moves.
- Compugen's Short-term Investments stood at $11.7 million in 2023, then surged by 422.88% to $61.4 million in 2024, then dropped by 25.47% to $45.8 million in 2025, then surged by 73.33% to $79.3 million in 2026.
- According to Business Quant data, Short-term Investments over the past three periods registered $79.3 million, $45.8 million, and $61.4 million for Q1 2026, Q4 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Compugen | 234.03 Mn | 142.28 Mn | 352,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 79.32 Mn |
| Dec 31, 2025 | 9.28 Mn |
| Dec 31, 2024 | 61.40 Mn |
| Dec 31, 2023 | 365,000.00 |
| Jun 30, 2023 | 615,000.00 |
| Jun 30, 2022 | 363,000.00 |
| Dec 31, 2021 | 109.25 Mn |
| Jun 30, 2021 | 681,000.00 |
| Dec 31, 2020 | 116.62 Mn |
| Jun 30, 2020 | 620,000.00 |
| Dec 31, 2019 | 652,000.00 |
| Jun 30, 2019 | 633,000.00 |
| Dec 31, 2018 | 605,000.00 |
| Jun 30, 2018 | 634,000.00 |
| Dec 31, 2017 | 1.05 Mn |
| Jun 30, 2017 | 1.05 Mn |
| Dec 31, 2016 | 993,000.00 |
| Jun 30, 2016 | 992,000.00 |
| Dec 31, 2015 | 1.08 Mn |
| Jun 30, 2015 | 546,000.00 |
| Mar 31, 2015 | 543,000.00 |
| Dec 31, 2014 | 543,000.00 |
| Jun 30, 2014 | 155,000.00 |
| Dec 31, 2013 | 154,000.00 |
| Sep 30, 2013 | 101,000.00 |
| Jun 30, 2013 | 99,000.00 |
| Mar 31, 2013 | 98,000.00 |
| Dec 31, 2012 | 3.22 Mn |
| Sep 30, 2012 | 91,000.00 |
| Jun 30, 2012 | 91,000.00 |
| Mar 31, 2012 | 95,000.00 |
| Dec 31, 2011 | 16.53 Mn |
| Sep 30, 2011 | 94,000.00 |
| Jun 30, 2011 | 102,000.00 |
| Mar 31, 2011 | 99,000.00 |
| Dec 31, 2010 | 14.52 Mn |
| Sep 30, 2010 | 155,000.00 |
| Jun 30, 2010 | 143,000.00 |
| Mar 31, 2010 | 152,000.00 |
| Dec 31, 2009 | 161,000.00 |